PORT-A-CATH II PS/Titan, Tray PAC II. Labeled as: a. VEN LP, PU, 2.6MM, UL, 8.5FR/INTRO (1/EA); b. DL, LP, PU, 2.2MM, WING-LOCK, 7FR/INTRO (1/EA); c. DL, LP, PU, 3.2MM, WING-LOCK, 10FR/INTRO (1/EA)
Published March 21, 2018 · Recall initiated: December 4, 2017
Summary
FDA records medical device Class II recall Z-1073-2018, published March 21, 2018 and initiated December 4, 2017. Recalling firm: Smiths Medical ASD Inc.; Status: Terminated; Reported quantity: 1,077 units total; Lot: a. Item No. 21-4071-24 (Lot No. 86X046, 87X050); b. Item No. 21-8066-24 (Lot No. 87X178); c. Item No. 21-8068-24 (Lot No. 87X179). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Certain models and lots of PORT A CATH implantable port kits may have been misassembled. The kits may incorrectly contain a 6Fr or 6.5Fr size introducer instead of the correct 8.5Fr size introducer. The Power PORT A CATH II kit may also contain the incorrect locking collars in addition to the incorrect sized introducer.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Smiths Medical ASD Inc.
- Distributor
- Worldwide Distribution. US nationwide including Puerto Rico, Austria, Bahamas, Belgium, Dominican Republic, Netherlands, Spain, and Turks and Caicos.
- Lot
- a. Item No. 21-4071-24 (Lot No. 86X046, 87X050); b. Item No. 21-8066-24 (Lot No. 87X178); c. Item No. 21-8068-24 (Lot No. 87X179)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACADD-Solis Li-ion Rechargeable Battery Packs, REF 21-2160-XX, which are also sold as a component of theNovember 6, 2024
- FDAENT RES, 100 ML, Non-Sterile W CLAMP & FEMALE LUER, Product Code 68-2231-28October 30, 2024
- FDACADD Medication Cassette Reservoir, 100mL, FS, Product Code 21-7302-24JPOctober 30, 2024
- FDACADD Medication Cassette Reservoir, 100mL, Product Code 21-7002-24October 30, 2024
- FDABrilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355March 28, 2018
- FDASTA - Neoplastine® Cl Plus ¿ (ref. 00606) Product Usage: Manual or automated determination of the prothrombinMarch 21, 2018
Questions about this recall
Was PORT-A-CATH II PS/Titan, Tray PAC II. Labeled as: a. VEN LP, PU, 2.6MM, UL, 8.5FR/INTRO (1/EA); b. DL, LP, PU, 2.2MM, WING-LOCK, 7FR/INTRO (1/EA); c. DL, LP, PU, 3.2MM, WING-LOCK, 10FR/INTRO (1/EA) recalled?
Yes. FDA published recall Z-1073-2018 on March 21, 2018. Reported hazard: Certain models and lots of PORT A CATH implantable port kits may have been misassembled. The kits may incorrectly contain a 6Fr or 6.5Fr size introducer instead of the correct 8.5Fr size introducer. The Power PORT A CATH II kit may also contain the incorrect locking collars in addition to the incorrect sized introducer.
What should I do if I have this product?
Voluntary: Firm initiated · Letter